NovoCure (NVCR) Cost of Revenue (2014 - 2026)
NovoCure (NVCR) posted Cost of Revenue of $41.1 million for Q2 2026, up 5.59% sequentially from $38.9 million in Q1 2026, and down 0.88% YoY from $41.5 million in Q2 2025.
NovoCure (NVCR) Cost of Revenue (2014 - 2026) Analysis & Trends
NovoCure has reported Cost of Revenue for 13 years, with the latest figure at $41.1 million in Q2 2026.
- Quarterly Cost of Revenue fell 0.88% year-over-year to $41.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $166.9 million (up 12.15% YoY) and the FY2025 annual result came in at $166.9 million, up 21.65% from the prior year.
- Cost of Revenue climbed to $41.1 million in Q2 2026 per NVCR's latest filing, from $38.9 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $44.7 million in Q3 2025 and troughed at $27.7 million in Q1 2022.
- A 5-year average of $34.8 million and a median of $33.9 million in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2022 and 2025: Cost of Revenue fell 2.69% in 2022, then increased 26.45% in 2025.
- Over 5 years, Cost of Revenue stood at $28.9 million in 2022, then increased by 12.7% to $32.6 million in 2023, then grew by 2.8% to $33.5 million in 2024, then grew by 25.97% to $42.2 million in 2025, then fell by 2.49% to $41.1 million in 2026.
- According to Business Quant data, Cost of Revenue over the past three periods registered $41.1 million, $38.9 million, and $42.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | 5.33 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 2.09 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 3.40 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | 392.40 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 478.40 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 2.25 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 2.57 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 808.60 Mn |
| 10 | NovoCure | 2.08 Bn | 1.64 Bn | 142.48 Mn | 41.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 41.11 Mn |
| Jun 30, 2026 | 41.11 Mn |
| Mar 31, 2026 | 38.93 Mn |
| Mar 31, 2026 | 38.93 Mn |
| Dec 31, 2025 | 42.16 Mn |
| Dec 31, 2025 | 42.16 Mn |
| Sep 30, 2025 | 44.73 Mn |
| Sep 30, 2025 | 44.73 Mn |
| Jun 30, 2025 | 41.47 Mn |
| Jun 30, 2025 | 41.47 Mn |
| Mar 31, 2025 | 38.52 Mn |
| Mar 31, 2025 | 38.52 Mn |
| Dec 31, 2024 | 33.47 Mn |
| Dec 31, 2024 | 33.47 Mn |
| Sep 30, 2024 | 35.37 Mn |
| Sep 30, 2024 | 35.37 Mn |
| Jun 30, 2024 | 34.65 Mn |
| Jun 30, 2024 | 34.65 Mn |
| Mar 31, 2024 | 33.69 Mn |
| Mar 31, 2024 | 33.69 Mn |